Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with Rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

P893

  • Mey, U.
  • Flieger, D.
  • Glasmacher, A.
  • Hahn, C.
  • Neubauer, A.
  • Birkmann, J.
  • Ho, A.
  • Kaiser, U.
  • Krämer, A.
  • Florschütz, A.
  • Wilhelm, M.
  • Haarmann, G.
  • Leo, E.
  • Gorschlüter, M.
  • Ziske, C.
  • Strehl, J.
  • Schmidt-Wolf, I.

  • Bonn, Aschaffenburg, Marburg, Nuremberg, Heidelberg, Hildesheim, Dessau, D

Onkologie 26:p 180, October 2003.
Copyright © 2003 S. Karger AG, Basel